» Articles » PMID: 16857692

The Four Ages of Down Syndrome

Overview
Specialty Public Health
Date 2006 Jul 22
PMID 16857692
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Down syndrome (DS) affects approximately 1 per 650-1000 live births and is the most common known genetic cause of intellectual disability. A highly significant change in the survival of people with DS has occurred during the last two generations, with life expectancy estimates increasing from 12 to nearly 60 years of age.

Subjects And Methods: Detailed information on 1332 people in Western Australia with DS was abstracted from a specialist statewide database for the period 1953-2000 and electronically linked with three other state or national health and mortality data sources and the state Birth Defects Registry.

Results: Over the last 25 years the percentage of women over 35 years giving birth increased from 4.8 to 18.6%, accompanied by an increase in the overall prevalence of DS from 1.1 to 2.9 per 1000 births. Four life stages of DS were identified: prenatal, childhood and early adulthood, adulthood, and senescence. Although pneumonia, or other types of respiratory infections, was the most common cause of death across the entire lifespan, ranging from 23% of deaths in adulthood to 40% in senescence, each life stage exhibited a particular profile of comorbidities. Congenital heart defects were common causes in childhood (13%) and adulthood (23%), whereas in senescence coronary artery disease (10%) and cardiac, renal, and respiratory failure (9%) were leading causes of mortality.

Conclusions: A major re-appraisal in attitudes towards DS is required to ensure that the medical and social needs of people with the disorder are adequately met across their entire lifespan. In particular, specific recognition of the comorbidities that can arise at different ages is needed, accompanied by the provision of appropriate levels of care and management.

Citing Articles

Down syndrome frontal cortex layer III and layer V pyramidal neurons exhibit lamina specific degeneration in aged individuals.

Alldred M, Ibrahim K, Pidikiti H, Chiosis G, Mufson E, Stutzmann G Acta Neuropathol Commun. 2024; 12(1):182.

PMID: 39605035 PMC: 11603868. DOI: 10.1186/s40478-024-01891-z.


Instruments for the assessment of quality of life in children and adolescents with Down syndrome: a scoping review.

Rodriguez-Grande E, Diaz Galvis M, Prieto P, Vargas-Pinilla O, Torres-Narvaez M, Rodriguez Malagon N BMC Pediatr. 2024; 24(1):688.

PMID: 39478472 PMC: 11523826. DOI: 10.1186/s12887-024-05028-y.


Clinical and neuropathological analysis of Down syndrome over 7 decades of life.

Sukreet S, Goodwill V, Ngolab J, Kim H, Leisher S, Salehi S J Neuropathol Exp Neurol. 2024; 84(2):168-173.

PMID: 39471466 PMC: 11747220. DOI: 10.1093/jnen/nlae110.


Outcomes in Adult Congenital Heart Disease Patients With Down Syndrome Undergoing a Cardiac Surgical Procedure.

Goldberg S, Chalak C, Anderson B, Elhoff J, Gaydos S, Lubert A Ann Thorac Surg. 2024; 119(2):398-405.

PMID: 39401550 PMC: 11741920. DOI: 10.1016/j.athoracsur.2024.09.037.


Structural Magnetic Resonance Imaging-Based Surface Morphometry Analysis of Pediatric Down Syndrome.

Levman J, McCann B, Baumer N, Lam M, Shiohama T, Cogger L Biology (Basel). 2024; 13(8).

PMID: 39194513 PMC: 11351698. DOI: 10.3390/biology13080575.